Surgical Innovations Group plc
("SI Group" or "the Company")
Director/PDMR Shareholding
The Company was notified on 23 March 2018 that on 22 March 2018 Melanie Ross, Chief Operating Officer, purchased 483,998 ordinary shares of 1 penny each in the Company ("Shares") for her ISA and her husband, Lee Ross purchased 483,998 Shares for his ISA, both at a price of 3.753p per share. To facilitate these purchases, also on 22 March 2018, Melanie Ross sold 967,996 Shares at a price of 3.75p each.
In addition, on 23 March 2018 Melanie Ross purchased 504,644 Shares at a price of 3.57p per share in an off-market transaction from Hardy Transaction Management Limited, which is wholly owned by Paul Hardy, a Non-Executive Director of the Company.
Following the transactions, the combined beneficial holding of Melanie Ross and her husband in the Company is 2,078,354 Shares, representing approximately 0.27% of the issued share capital and the beneficial holding of Paul Hardy is 6,225,541 Shares, representing 0.80% of the issued share capital.
For further information please contact:
Surgical Innovations Group Plc |
||
Nigel Rogers, Executive Chairman |
Tel: 0113 230 7597 |
|
Melanie Ross, COO & Finance Director |
|
|
|
|
|
WH Ireland Limited (NOMAD & Broker) |
|
|
Tim Feather / Alex Bond
|
Tel: 0113 394 6600
|
|
Walbrook PR (Financial PR & Investor Relations) |
Tel: 020 7933 8780 or si@walbrookpr.com |
|
Paul McManus |
Mob: 07980 541 893 |
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||
a) |
Name |
Melanie Ross |
|||
2 |
Reason for the notification |
||||
a) |
Position/status |
Chief Operating Officer, Surgical Innovations Group plc |
|||
b) |
Initial notification/ Amendment |
Initial Notification |
|||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
a) |
Name |
Surgical Innovations Group plc |
|||
b) |
LEI |
2138004GHGUH3HUZE156 |
|||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 1p
GB0004016704 |
|||
b) |
Nature of the transactions |
Sale of Ordinary Shares |
|||
c) |
Price(s) and volume(s) |
|
Price(s) |
Volume(s) |
|
3.75p |
967,996 |
||||
|
|||||
d) |
Aggregated information - Aggregated volume - Price |
967,996 £36,300 |
|||
e) |
Date of the transaction |
22 March 2018
|
|||
f) |
Place of the transaction |
London Stock Exchange, AIM
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||
a) |
Name |
Melanie Ross |
|||
2 |
Reason for the notification |
||||
a) |
Position/status |
Chief Operating Officer, Surgical Innovations Group plc |
|||
b) |
Initial notification/ Amendment |
Initial Notification |
|||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
a) |
Name |
Surgical Innovations Group plc |
|||
b) |
LEI |
2138004GHGUH3HUZE156 |
|||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 1p
GB0004016704 |
|||
b) |
Nature of the transactions |
1. Purchase of shares in ISA 2. Purchase of shares by husband 3. Purchase of shares |
|||
5. |
Price(s) and volume(s) |
|
Price(s) |
Volume(s) |
|
3.75p |
483,998 |
||||
|
3.75p |
483,998 |
|
||
|
3.57p |
504,644 |
|
||
|
|||||
d) |
Aggregated information - Aggregated volume - Price |
1,472,640 £54,316 |
|||
e) |
Date of the transaction |
1. & 2. - 22 March 2018 3.- 23 March 2018 |
|||
f) |
Place of the transaction |
1. & 2. - London Stock Exchange, AIM 3. - Off market |
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||
a) |
Name |
Paul Hardy |
|||
2 |
Reason for the notification |
||||
a) |
Position/status |
Non-Executive Director, Surgical Innovations Group plc |
|||
b) |
Initial notification/ Amendment |
Initial Notification |
|||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
a) |
Name |
Surgical Innovations Group plc |
|||
b) |
LEI |
2138004GHGUH3HUZE156 |
|||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 1p
GB0004016704 |
|||
b) |
Nature of the transactions |
Sale of Ordinary Shares |
|||
c) |
Price(s) and volume(s) |
|
Price(s) |
Volume(s) |
|
3.57p |
504,644 |
||||
|
|||||
d) |
Aggregated information - Aggregated volume - Price |
504,644 £18,016 |
|||
e) |
Date of the transaction |
23 March 2018 |
|||
f) |
Place of the transaction |
Off market |